Cannot redeclare control with same name "grid_4_qv_container_background_attachment"
Activating GLP-1R significantly inhibited the TGF-1 + IL-1-induced increase in GlycoPER and OCR, indicating that GLP-1R may be an important target for maintaining metabolic homeostasis in activated fibroblasts during pulmonary fibrosis
Cancer cells display an exceptional neoplastic metabolism and heightened reactive oxygen species (ROS) attributes [5,6,7,8]
Your primary research question dictates the most appropriate delivery method
Annual per-patient costs of $12,000 to $16,000 for brand-name GLP-1 medications, combined with the massive number of potentially eligible patients (roughly 42% of American adults have obesity), create projected costs that threaten to destabilize employer health plans
A.BrningA.CappelloF.ChangW.-W.CvekB.et al (2013)